{"entity":{"type":"insider","cik":"0001869057","url":"/insider/0001869057","json_url":"/insider/0001869057.json","name":"Blue Horizon Enterprise Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2022-12-05","last":"2025-06-06","span_basis":"filed_date"},"name_variants":[{"name":"Blue Horizon Enterprise Ltd","source":"filing","n_filings":5,"first_seen":"2022-12-05","last_seen":"2025-06-06"}],"transactions":[{"id":4985618,"accession":"0001062993-25-011153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-011153","line_url":"/filing/0001062993-25-011153#line-1","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":null,"owner_name":"Skorpios Trust; Montrago Trustees Ltd; Ezbon International Ltd; Blue Horizon Enterprise Ltd","owner_display_name":"Skorpios Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000000.0,"shares_display":"3,000,000","price_per_share":10.2,"price_display":"10.20","price_state":"stated","total_value":30600000.0,"total_display":"30,600,000.00","total_whole":"30,600,000","shares_owned_after":3906181.0,"shares_owned_after_display":"3,906,181","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-06","scope":"insider"},{"id":2528475,"accession":"0001062993-24-021228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-021228","line_url":"/filing/0001062993-24-021228#line-1","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":null,"owner_name":"Ezbon International Ltd; Montrago Trustees Ltd; Skorpios Trust; Blue Horizon Enterprise Ltd","owner_display_name":"Ezbon International Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":23000000.0,"total_display":"23,000,000.00","total_whole":"23,000,000","shares_owned_after":6906181.0,"shares_owned_after_display":"6,906,181","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-27","scope":"insider"},{"id":3231144,"accession":"0001062993-24-016894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-016894","line_url":"/filing/0001062993-24-016894#line-1","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":null,"owner_name":"Montrago Trustees Ltd; Blue Horizon Enterprise Ltd; Ezbon International Ltd; Skorpios Trust","owner_display_name":"Montrago Trustees Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1937500.0,"shares_display":"1,937,500","price_per_share":14.05,"price_display":"14.05","price_state":"stated","total_value":27221875.0,"total_display":"27,221,875.00","total_whole":"27,221,875","shares_owned_after":8906181.0,"shares_owned_after_display":"8,906,181","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-19","filed_date":"2024-09-23","scope":"insider"},{"id":3153468,"accession":"0001062993-24-008547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-008547","line_url":"/filing/0001062993-24-008547#line-1","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":null,"owner_name":"Skorpios Trust; Ezbon International Ltd; Blue Horizon Enterprise Ltd; Montrago Trustees Ltd","owner_display_name":"Skorpios Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600000.0,"shares_display":"3,600,000","price_per_share":11.6,"price_display":"11.60","price_state":"stated","total_value":41760000.0,"total_display":"41,760,000.00","total_whole":"41,760,000","shares_owned_after":10843681.0,"shares_owned_after_display":"10,843,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-17","filed_date":"2024-04-18","scope":"insider"},{"id":6647960,"accession":"0001062993-22-023333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-023333","line_url":"/filing/0001062993-22-023333#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":null,"owner_name":"Blue Horizon Enterprise Ltd; Skorpios Trust; Ezbon International Ltd; Montrago Trustees Ltd","owner_display_name":"Blue Horizon Enterprise Ltd","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1636000.0,"shares_display":"1,636,000","price_per_share":43.5,"price_display":"43.50","price_state":"stated","total_value":71166000.0,"total_display":"71,166,000.00","total_whole":"71,166,000","shares_owned_after":3271829.0,"shares_owned_after_display":"3,271,829","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623526","name":"Stoke Therapeutics, Inc.","url":"/issuer/0001623526","role":"Ten percent owner","n_filings":4,"first_seen":"2024-04-18","last_seen":"2025-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001744659","name":"Akero Therapeutics, Inc.","url":"/issuer/0001744659","role":"Other","n_filings":1,"first_seen":"2022-12-05","last_seen":"2022-12-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001869057","retrieved_at":"2026-08-23T20:26:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}